< -5%

-5% to -3%

Guj Mineral

-3% to 0%

Coal India

0% to 3%

Abhishek Integr

3% to 5%

Axis Bank shares rose over 4 percent on Thursday after the lender reported improved asset quality in its September quarter results, helping the Bank Nifty index climb past the 57,000 mark.

The stock rose 4.04 percent to an intraday high of Rs 1,216.90 on the NSE, after opening with a 4 percent gain. The rise came after two consecutive sessions of decline.

According to data compiled by LSEG, at least eight of the 40 brokerages tracking <a href="https://www.moneycontrol.com/india/stockpricequote/banks-private-sector/axisbank/AB16">Axis Bank</a> raised their price targets following the results.

"Improvements have been substantial, including credit cost decline and better-than-estimated net interest margin resilience," analysts at HSBC said in a note.

HSBC raised its target price on the stock to Rs 1,460 from Rs 1,340. Jefferies also increased its price target to Rs 1,430 from Rs 1,370 and retained its “buy” rating.

Axis Bank on Wednesday reported a sharper-than-expected drop in quarterly profit, but total deposits grew 11 percent year-on-year and credit costs declined.

Its net interest margin fell to 3.73 percent from 3.8 percent in the previous quarter and 3.99 percent in the year-ago period. Jefferies had expected a 20-basis-point sequential decline in margins, while the bank reported a 7-basis-point fall, which analysts viewed as a positive sign.

The Bank Nifty index recovered from previous day losses to trade above 57,000, with analysts at Choice Broking identifying resistance at 57,100–57,200. A breakout above this range could take the index towards 57,500, they added.

Axis Bank was the top gainer on the index, followed by <a href="https://www.moneycontrol.com/india/stockpricequote/banks-private-sector/kotakmahindrabank/KMB">Kotak Mahindra Bank</a>, which rose up to 2 percent intraday. Punjab National Bank, HDFC Bank, ICICI Bank and IndusInd Bank were also among the gainers.

Investor sentiment in the banking space was further supported by <a href="https://www.moneycontrol.com/news/business/economy/govt-draws-up-mega-bank-merger-plan-smaller-lenders-to-be-clubbed-with-big-banks-by-fy27-13617103.html" target="_blank">reports of a potential public sector bank consolidation</a>, with government sources indicating that the Centre is working on a merger plan to combine smaller lenders with larger state-run banks.

(Inputs from Reuters)

Disclaimer: The views and investment tips expressed by experts on Moneycontrol are their own and not those of the website or its management. Moneycontrol advises users to check with certified experts before taking any investment decisions.

A financial journalist with over 10 years of experience, specialising in tracking stock market movements and fundamental developments that impact investors and the broader economy. A keen observer of global financial markets, I regularly engage with leading market voices to write stories. At Moneycontrol, I focus on decoding market trends, policy shifts and economic changes, driven by a constant passion to learn, analyse, and share knowledge with my readers.

Ownership, Material Conflicts of Interest and Disciplinary History

MCD is a wholly owned subsidiary of Network 18 Media & Investments Ltd ("Network18"), in which Independent Media Trust (IMT) holds 56.89% stake. Reliance Industries Limited ("RIL") is the sole beneficiary of IMT. Network18 and RIL and their subsidiaries, joint ventures and associates can be considered as associates of MCD.

Details of Associate

Receipt of Compensation

Third-Party Compensation

Employment History

Market-Making Activities

Use of Artificial Intelligence

Axis Bank Q2 results propel Bank Nifty past 57,000; analysts say 57,500 is next resistance

Axis Bank shares rose over 4 percent on Thursday after the lender reported improved asset quality in its September quarter results, helping the Bank Nifty index climb past the 57,000 mark.

The stock rose 4.04 percent to an intraday high of Rs 1,216.90 on the NSE, after opening with a 4 percent gain. The rise came after two consecutive sessions of decline.

According to data compiled by LSEG, at least eight of the 40 brokerages tracking Axis Bank raised their price targets following the results.

&quot;Improvements have been substantial, including credit cost decline and better-than-estimated net interest margin resilience,&quot; analysts at HSBC said in a note.

HSBC raised its target price on the stock to Rs 1,460 from Rs 1,340. Jefferies also increased its price target to Rs 1,430 from Rs 1,370 and retained its “buy” rating.

Axis Bank on Wednesday reported a sharper-than-expected drop in quarterly profit, but total deposits grew 11 percent year-on-year and credit costs declined.

Its net interest margin fell to 3.73 percent from 3.8 percent in the previous quarter and 3.99 percent in the year-ago period. Jefferies had expected a 20-basis-point sequential decline in margins, while the bank reported a 7-basis-point fall, which analysts viewed as a positive sign.

The Bank Nifty index recovered from previous day losses to trade above 57,000, with analysts at Choice Broking identifying resistance at 57,100–57,200. A breakout above this range could take the index towards 57,500, they added.

Axis Bank was the top gainer on the index, followed by Kotak Mahindra Bank, which rose up to 2 percent intraday. Punjab National Bank, HDFC Bank, ICICI Bank and IndusInd Bank were also among the gainers.

Investor sentiment in the banking space was further supported by reports of a potential public sector bank consolidation, with government sources indicating that the Centre is working on a merger plan to combine smaller lenders with larger state-run banks.

(Inputs from Reuters)

Disclaimer: The views and investment tips expressed by experts on Moneycontrol are their own and not those of the website or its management. Moneycontrol advises users to check with certified experts before taking any investment decisions.

The shares of <a href="https://www.moneycontrol.com/ipo/canara-robeco-asset-management-company-ltd-cramcl-ipodetail">Canara Robeco Asset Management Company</a> made a tepid stock market debut on October 16, listing at Rs 280.25 apiece on NSE. This marks a premium of 5.36 percent over the IPO price of Rs 266 apiece.

On BSE too, the shares listed at Rs 280.25 apiece. The stock's market capitalization at debut stood at Rs 5,589 crore.

The stock then jumped more than 12 percent to hit a day's high of Rs 315 apiece. This marks a jump of more than 18 percent from the IPO price. The mcap has now crossed Rs 6,072 crore.

Canara Robeco AMC IPO GMP:

The listing premium is slightly lower than the grey market estimates. Ahead of listing, the unlisted shares of the company were trading with more than 8 percent grey market premium (GMP) over the IPO price, according to data on Investorgain.

According to IPO Watch, the unlisted shares of the company were trading with more than 7.5 percent GMP over the IPO price, ahead of listing.

About Canara Robeco AMC IPO:

The initial public offering of Canara Robeco saw strong investor interest during its three days of public bidding, being subscribed nearly 10 times (974 percent) between October 9 and October 13 at a price band of Rs 253-266 apiece.

The Rs 1,326-crore IPO entirely comprised an offer for sale (OFS) of nearly 5 crore shares, with no fresh issue component. This means that none of the IPO proceeds will go to the company as they will be received by the selling promoters. Currently, Canara Bank owns 51 percent stake in Canara Robeco while Orix Corporation holding has the remaining stake in the AMC.

PL Capital initiates coverage with 'Buy' rating:

PL Capital initiated coverage on the shares of Canara Robeco Asset Management Company with a 'Buy' rating. This came a day before the shares made their debut on stock markets on October 16.

The domestic brokerage kept a target price of Rs 320 per share for the stock, implying an upside potential of more than 20 percent from the IPO price of Rs 266 apiece.

What PL Capital said:

PL Capital said that it is initiating coverage on the stock with a <a href="https://www.moneycontrol.com/news/business/markets/canara-robeco-amc-gets-buy-call-from-brokerage-ahead-of-market-debut-up-to-20-upside-seen-13618176.html">'Buy' rating</a> as it is optimistic about its business prospects, given its better equity performance, higher equity share of 90 percent which could lead to higher core earnings, and telescopic pricing which would have a limited impact on equity yields.

"We see healthy core earnings CAGR of 17% over FY25-28E, better than listed peers. Upper band of Rs 266 suggests a value of 19.6x on Sep'27 core EPS (UTIAM: 16.7x, ABSLAMC: 22.7x), indicating 42.5% discount to NAM. We assign 24x multiple to arrive at TP of Rs 320; CRAMC is attractive in the small-cap space. Initiate with 'BUY'," it said.

The domestic brokerage also noted that being a subsidiary of Canara Bank, the about-to-be-listed AMC firm benefits from the bank’s widespread branch network and retail customer base, facilitating distribution of MF products across the country

Follow all IPO news <a href="https://www.moneycontrol.com/ipo/">here</a>.

Disclaimer: The views and investment tips expressed by experts on Moneycontrol are their own and not those of the website or its management. Moneycontrol advises users to check with certified experts before taking any investment decisions.

Canara Robeco AMC shares jump 12% after listing at 5% premium over IPO price

The shares of Canara Robeco Asset Management Company made a tepid stock market debut on October 16, listing at Rs 280.25 apiece on NSE. This marks a premium of 5.36 percent over the IPO price of Rs 266 apiece.

On BSE too, the shares listed at Rs 280.25 apiece. The stock's market capitalization at debut stood at Rs 5,589 crore.

The stock then jumped more than 12 percent to hit a day's high of Rs 315 apiece. This marks a jump of more than 18 percent from the IPO price. The mcap has now crossed Rs 6,072 crore.

Canara Robeco AMC IPO GMP:

The listing premium is slightly lower than the grey market estimates. Ahead of listing, the unlisted shares of the company were trading with more than 8 percent grey market premium (GMP) over the IPO price, according to data on Investorgain.

According to IPO Watch, the unlisted shares of the company were trading with more than 7.5 percent GMP over the IPO price, ahead of listing.

About Canara Robeco AMC IPO:

The initial public offering of Canara Robeco saw strong investor interest during its three days of public bidding, being subscribed nearly 10 times (974 percent) between October 9 and October 13 at a price band of Rs 253-266 apiece.

The Rs 1,326-crore IPO entirely comprised an offer for sale (OFS) of nearly 5 crore shares, with no fresh issue component. This means that none of the IPO proceeds will go to the company as they will be received by the selling promoters. Currently, Canara Bank owns 51 percent stake in Canara Robeco while Orix Corporation holding has the remaining stake in the AMC.

PL Capital initiates coverage with 'Buy' rating:

PL Capital initiated coverage on the shares of Canara Robeco Asset Management Company with a 'Buy' rating. This came a day before the shares made their debut on stock markets on October 16.

The domestic brokerage kept a target price of Rs 320 per share for the stock, implying an upside potential of more than 20 percent from the IPO price of Rs 266 apiece.

What PL Capital said:

PL Capital said that it is initiating coverage on the stock with a 'Buy' rating as it is optimistic about its business prospects, given its better equity performance, higher equity share of 90 percent which could lead to higher core earnings, and telescopic pricing which would have a limited impact on equity yields.

&quot;We see healthy core earnings CAGR of 17% over FY25-28E, better than listed peers. Upper band of Rs 266 suggests a value of 19.6x on Sep'27 core EPS (UTIAM: 16.7x, ABSLAMC: 22.7x), indicating 42.5% discount to NAM. We assign 24x multiple to arrive at TP of Rs 320; CRAMC is attractive in the small-cap space. Initiate with 'BUY',&quot; it said.

The domestic brokerage also noted that being a subsidiary of Canara Bank, the about-to-be-listed AMC firm benefits from the bank’s widespread branch network and retail customer base, facilitating distribution of MF products across the country

Follow all IPO news here.

Disclaimer: The views and investment tips expressed by experts on Moneycontrol are their own and not those of the website or its management. Moneycontrol advises users to check with certified experts before taking any investment decisions.

The shares of <a href="https://www.moneycontrol.com/ipo/rubicon-research-ltd-rrl04-ipodetail">Rubicon Research</a> made a strong stock market debut on October 16, listing at Rs 620 apiece on NSE. This marks a premium of 27.84 percent over the IPO price of Rs 485 apiece.

On BSE, the shares listed at Rs 620.10 apiece, marking a premium of 27.86 percent over the IPO price. The market capitalization of the stock during debut stood at Rs 10,216 crore.

Market debut misses grey market estimates:

The listing premium however, slightly missed grey market estimates. Ahead of listing, the unlisted shares of the company were trading with nearly 30 percent grey market premium (GMP) over the IPO price, according to data on Investorgain.

According to IPO Watch, the unlisted shares of the company were trading with nearly 30 percent GMP over the issue price.

Key things to know about Rubicon Research IPO:

Rubicon Research launched its initial public offering to raise Rs 1,377.50 crore through a fresh issue of shares worth Rs 500 crore and an offer for sale (OFS) of shares worth Rs 877.5 crore worth shares by promoter General Atlantic Singapore RR. The price band for the IPO was set at Rs 461-485 per share.

The maiden public issue of the company saw <a href="https://www.moneycontrol.com/news/business/ipo/rubicon-research-ipo-sees-11-times-subscription-on-day-3-so-far-check-latest-gmp-13612220.html">strong investor interest</a> during its three days of public bidding, being subscribed 48 times between October 9 and October 13. Non-institutional investors showed the most interest, subscribing their reserved portion over 80 times.

How will the IPO proceeds be used?

Rubicon Research aims to use Rs 310 crore of the fresh issue proceeds for repayment of its certain borrowings, and the remaining amount for inorganic growth through unidentified acquisitions and general corporate purposes.

What analysts say:

"With almost 98% of revenues derived from the U.S., the company exhibits robust international competitiveness, although geopolitical and regulatory risks exist...The IPO highlights the appeal of a scalable, high-margin business, offering investors a chance to diversify into markets enjoying foreign inflows and long-term growth opportunities," said Siddharth Maurya, Founder &amp; Managing Director, Vibhavangal Anukulakara.

HDFC Securities in its note said that Rubicon Research was the fastest growing Indian pharmaceuticals formulations company between fiscal years 2023 and 2025, with a total revenue CAGR of 75.89%, which was over seven times higher than the average of 11 companies.

"Rubicon Research has established robust sales and distribution capabilities in the US, anchored by its wholly-owned subsidiary, AdvaGen Pharma. AdvaGen markets non-branded prescription products to a diverse customer base that includes wholesalers, group purchasing organizations (“GPOs”), and pharmacy chains," it said.

Follow all IPO news <a href="https://www.moneycontrol.com/ipo/">here</a>.

Disclaimer: The views and investment tips expressed by experts on Moneycontrol are their own and not those of the website or its management. Moneycontrol advises users to check with certified experts before taking any investment decisions.

Rubicon Research shares make strong market debut, list at 28% premium over IPO price

Rubicon Research share price make strong market debut, list at 28% premium over IPO price

The shares of Rubicon Research made a strong stock market debut on October 16, listing at Rs 620 apiece on NSE. This marks a premium of 27.84 percent over the IPO price of Rs 485 apiece.

On BSE, the shares listed at Rs 620.10 apiece, marking a premium of 27.86 percent over the IPO price. The market capitalization of the stock during debut stood at Rs 10,216 crore.

Market debut misses grey market estimates:

The listing premium however, slightly missed grey market estimates. Ahead of listing, the unlisted shares of the company were trading with nearly 30 percent grey market premium (GMP) over the IPO price, according to data on Investorgain.

According to IPO Watch, the unlisted shares of the company were trading with nearly 30 percent GMP over the issue price.

Key things to know about Rubicon Research IPO:

Rubicon Research launched its initial public offering to raise Rs 1,377.50 crore through a fresh issue of shares worth Rs 500 crore and an offer for sale (OFS) of shares worth Rs 877.5 crore worth shares by promoter General Atlantic Singapore RR. The price band for the IPO was set at Rs 461-485 per share.

The maiden public issue of the company saw strong investor interest during its three days of public bidding, being subscribed 48 times between October 9 and October 13. Non-institutional investors showed the most interest, subscribing their reserved portion over 80 times.

How will the IPO proceeds be used?

Rubicon Research aims to use Rs 310 crore of the fresh issue proceeds for repayment of its certain borrowings, and the remaining amount for inorganic growth through unidentified acquisitions and general corporate purposes.

What analysts say:

&quot;With almost 98% of revenues derived from the U.S., the company exhibits robust international competitiveness, although geopolitical and regulatory risks exist...The IPO highlights the appeal of a scalable, high-margin business, offering investors a chance to diversify into markets enjoying foreign inflows and long-term growth opportunities,&quot; said Siddharth Maurya, Founder &amp;amp; Managing Director, Vibhavangal Anukulakara.

HDFC Securities in its note said that Rubicon Research was the fastest growing Indian pharmaceuticals formulations company between fiscal years 2023 and 2025, with a total revenue CAGR of 75.89%, which was over seven times higher than the average of 11 companies.

&quot;Rubicon Research has established robust sales and distribution capabilities in the US, anchored by its wholly-owned subsidiary, AdvaGen Pharma. AdvaGen markets non-branded prescription products to a diverse customer base that includes wholesalers, group purchasing organizations (“GPOs”), and pharmacy chains,&quot; it said.

Follow all IPO news here.

Disclaimer: The views and investment tips expressed by experts on Moneycontrol are their own and not those of the website or its management. Moneycontrol advises users to check with certified experts before taking any investment decisions.

<a href="https://www.moneycontrol.com/india/stockpricequote/infrastructure-general/powermechprojects/PMP">Power Mech Projects</a> share price down marginally in the opening trade on October 16 following the company received a work order from Bharat Heavy Electricals (BHEL) of Rs 2500 crore.

At 09:29am, Power Mech Projects was quoting at Rs 2,775.70, down Rs 4.20, or 0.15 percent, on the BSE.

".... has been awarded balance of plant package on EPC basis for 1 x 800 MW Singareni TPS, Stage-II, by Bharat Heavy Electricals for a value over Rs 2500 crores excl. GST," company said in its release.

The scope of work under the contract includes engineering, procurement &amp; construction of coal and biomass handling system, ash handling system, utilities, induced draft cooling tower (IDCT), water and wastewater treatment plant, fire protection system associated civil &amp; structural works and electrical, C&amp;I.

<a href="https://www.moneycontrol.com/news/business/markets/stock-market-live-sensex-nifty-50-share-price-gift-nifty-latest-updates-16-10-2025-liveblog-13618831.html">Catch all the market action on our live blog</a>

In the month of August, the company secured RS 370.84 croreorder from Mahan Energen, subsidiary of Adani Power, for execution of civil works and erection of prefabricated structural steel for BTG unit 1 &amp; 2 for Mahan Phase-III (2 x 800 MW), Mahan Energen Limited, Singrauli, Madhya Pradesh.

In the previous trading session, the share closed at Rs 2,779.90, down Rs 43.45, or 1.54 percent.

The share touched a 52-week high of Rs 3,415.45 and a 52-week low of Rs 1,698.85 on 10 July, 2025 and 03 March, 2025, respectively.

Currently, the stock is trading 18.73 percent below its 52-week high and 63.39 percent above its 52-week low.

The market capitalisation of the company stands at Rs 8,775.73 crore.

Power Mech Projects shares down marginally despite order win worth Rs 2500 crore

Power Mech Projects share price down marginally in the opening trade on October 16 following the company received a work order from Bharat Heavy Electricals (BHEL) of Rs 2500 crore.

At 09:29am, Power Mech Projects was quoting at Rs 2,775.70, down Rs 4.20, or 0.15 percent, on the BSE.

&quot;.... has been awarded balance of plant package on EPC basis for 1 x 800 MW Singareni TPS, Stage-II, by Bharat Heavy Electricals for a value over Rs 2500 crores excl. GST,&quot; company said in its release.

The scope of work under the contract includes engineering, procurement &amp;amp; construction of coal and biomass handling system, ash handling system, utilities, induced draft cooling tower (IDCT), water and wastewater treatment plant, fire protection system associated civil &amp;amp; structural works and electrical, C&amp;amp;I.

Catch all the market action on our live blog

In the month of August, the company secured RS 370.84 croreorder from Mahan Energen, subsidiary of Adani Power, for execution of civil works and erection of prefabricated structural steel for BTG unit 1 &amp;amp; 2 for Mahan Phase-III (2 x 800 MW), Mahan Energen Limited, Singrauli, Madhya Pradesh.

In the previous trading session, the share closed at Rs 2,779.90, down Rs 43.45, or 1.54 percent.

The share touched a 52-week high of Rs 3,415.45 and a 52-week low of Rs 1,698.85 on 10 July, 2025 and 03 March, 2025, respectively.

Currently, the stock is trading 18.73 percent below its 52-week high and 63.39 percent above its 52-week low.

The market capitalisation of the company stands at Rs 8,775.73 crore.

<a href="https://www.moneycontrol.com/india/stockpricequote/power-transmissionequipment/kecinternational/KEC04">KEC International</a> share price snapped two-day fall, rising 0.5 percent in the opening trade on October 16 following the company won new order for installation of 380 kV GIS substation in Saudi Arabia.

At 09:20 hrs KEC International was quoting at Rs 854.70, up Rs 4.15, or 0.49 percent, on the BSE.

"....... has secured a new order of Rs 1,038 crore for design, supply and installation of 380 kV GIS substation in Saudi Arabia," company said in its press release.

“We are delighted with the successive order wins in our T&amp;D business. In a landmark achievement, we have secured our largest ever substation order. This prestigious order in the Middle East has widened our portfolio and strengthened our presence in the region. With this strategic win, our YTD order intake has surpassed Rs 16,000 crore, representing a healthy growth of ~20%,” said Vimal Kejriwal, MD &amp; CEO, KEC International.

<a href="https://www.moneycontrol.com/news/business/markets/stock-market-live-updates-gift-nifty-indicates-a-strong-start-us-asian-markets-gain-liveblog-13618831.html">Catch all the market action on our live blog</a>

Earlier in this week, company secured a new order of Rs 1,064 crore for design, supply and installation of 380 kV transmission line in Saudi Arabia and Rs 1,174 crore for transmission &amp; distribution projects in India and the Middle East.

Last week, the company secured new orders of Rs 1,102 crore across various businesses.

In the previous trading session, at Rs 857.90, down Rs 0.35, or 0.04 percent.

The share touched a 52-week high of Rs 1,312.00 and a 52-week low of Rs 605.05 on 04 December, 2024 and 07 April, 2025, respectively.

Currently, the stock is trading 34.86 percent below its 52-week high and 41.26 percent above its 52-week low.

The market capitalisation of the company stands at Rs 22,752.11 crore.

KEC International shares gain on order win of Rs 1,038 crore

KEC International share price snapped two-day fall, rising 0.5 percent in the opening trade on October 16 following the company won new order for installation of 380 kV GIS substation in Saudi Arabia.

At 09:20 hrs KEC International was quoting at Rs 854.70, up Rs 4.15, or 0.49 percent, on the BSE.

&quot;....... has secured a new order of Rs 1,038 crore for design, supply and installation of 380 kV GIS substation in Saudi Arabia,&quot; company said in its press release.

“We are delighted with the successive order wins in our T&amp;amp;D business. In a landmark achievement, we have secured our largest ever substation order. This prestigious order in the Middle East has widened our portfolio and strengthened our presence in the region. With this strategic win, our YTD order intake has surpassed Rs 16,000 crore, representing a healthy growth of ~20%,” said Vimal Kejriwal, MD &amp;amp; CEO, KEC International.

Catch all the market action on our live blog

Earlier in this week, company secured a new order of Rs 1,064 crore for design, supply and installation of 380 kV transmission line in Saudi Arabia and Rs 1,174 crore for transmission &amp;amp; distribution projects in India and the Middle East.

Last week, the company secured new orders of Rs 1,102 crore across various businesses.

In the previous trading session, at Rs 857.90, down Rs 0.35, or 0.04 percent.

The share touched a 52-week high of Rs 1,312.00 and a 52-week low of Rs 605.05 on 04 December, 2024 and 07 April, 2025, respectively.

Currently, the stock is trading 34.86 percent below its 52-week high and 41.26 percent above its 52-week low.

The market capitalisation of the company stands at Rs 22,752.11 crore.

Coal Industry Stocks
Check latest stock performance, list of stocks, earnings review & more details about the Coal industry stocks.

Gainers/Losers

Industry Market Map

Earnings Review-Q2 FY25-26

Stock News

Axis Bank Q2 results propel Bank Nifty past 57,000; analysts say 57,500 is next resistance

Canara Robeco AMC shares jump 12% after listing at 5% premium over IPO price

Rubicon Research shares make strong market debut, list at 28% premium over IPO price

Power Mech Projects shares down marginally despite order win worth Rs 2500 crore

KEC International shares gain on order win of Rs 1,038 crore

Coal Industry StocksCheck latest stock performance, list of stocks, earnings review & more details about the Coal industry stocks.

Gainers/Losers

Industry Market Map

Earnings Review-Q2 FY25-26

Stock News

Axis Bank Q2 results propel Bank Nifty past 57,000; analysts say 57,500 is next resistance

Canara Robeco AMC shares jump 12% after listing at 5% premium over IPO price

Rubicon Research shares make strong market debut, list at 28% premium over IPO price

Power Mech Projects shares down marginally despite order win worth Rs 2500 crore

KEC International shares gain on order win of Rs 1,038 crore

Coal Industry Stocks
Check latest stock performance, list of stocks, earnings review & more details about the Coal industry stocks.